Gilligan, James P
Tarsa Therapeutics, Inc., Philadelphia, PA, USA
3 papers on CoChat
Most cited papers
- Verified
A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial
Binkley, N., Bolognese, M., Sidorowicz-Bialynicka, A., Vally, T., Trout, R., Miller, C., Buben, C. E., Gilligan, J. P., Krause, D. S., & for the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) Investigators (2012) · Journal of Bone and Mineral Research
Bone health and osteoporosis researchMenopause: Health Impacts and Treatments
Cited by 149
- Verified
Targeted Expression of Calcitonin Gene-Related Peptide to Osteoblasts Increases Bone Density in Mice
Ballica, R., Valentijn, K., Khachatryan, A., Guerder, S., Kapadia, S., Gundberg, C., Gilligan, J., Flavell, R. A., & Vignery, A. (1999) · Journal of Bone and Mineral Research
Bone Metabolism and DiseasesBone health and osteoporosis research
Cited by 133
- Verified
Effects of calcitonin gene-related peptide on bone turnover in ovariectomized rats
Valentijn, K., Gutow, A. P., Troiano, N., Gundberg, C., Gilligan, J. P., & Vignery, A. (1997) · Bone
Bone Metabolism and DiseasesBone health and osteoporosis research
Cited by 89
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free